New injectable schizophrenia drug enters early human testing
NCT ID NCT07061288
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This early-stage study is testing a long-acting injectable form of the drug KarXT in 116 people with schizophrenia. The main goal is to check the drug's safety and how the body processes it. Researchers hope this injectable version could offer a more convenient treatment option that lasts longer between doses.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
KarXT (also known as BMS-986510)
What this could lead to
If successful, this could lead to a longer-lasting injectable treatment option for schizophrenia, potentially improving medication adherence and symptom control.
What could go wrong
This is an early Phase 1 study focused on safety and dosing, not yet on effectiveness. The injectable form may cause side effects or not work as well as the oral version. Results are preliminary and may not lead to a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Atlanta Center for Medical Research
RECRUITINGAtlanta, Georgia, 30331, United States
Contact Phone: •••-•••-••••
-
CenExel iResearch, LLC
RECRUITINGDecatur, Georgia, 30030, United States
Contact Phone: •••-•••-••••
-
Collaborative Neuroscience Research, LLC
RECRUITINGLos Alamitos, California, 90720-3118, United States
Contact Phone: •••-•••-••••
-
Community Clinical Research
RECRUITINGAustin, Texas, 78754, United States
Contact Phone: •••-•••-••••
-
Hassman Research Institute Marlton Site
RECRUITINGMarlton, New Jersey, 08053, United States
Contact Phone: •••-•••-••••
-
Innovative Clinical Research, Inc.
RECRUITINGMiami Lakes, Florida, 33016, United States
Contact Phone: •••-•••-••••
-
Research Centers of America ( Hollywood )
RECRUITINGHollywood, Florida, 33024, United States
Contact Phone: •••-•••-••••
-
Uptown Research Institute
RECRUITINGChicago, Illinois, 60640, United States
Contact Phone: •••-•••-••••